A 30 week, forced titration and randomised, crossover, multicentre, multinational trial to evaluate the efficacy and safety of rosuvastatin and atorvastatin in subjects with homozygous familial hypercholesterolemia

Trial Profile

A 30 week, forced titration and randomised, crossover, multicentre, multinational trial to evaluate the efficacy and safety of rosuvastatin and atorvastatin in subjects with homozygous familial hypercholesterolemia

Completed
Phase of Trial: Phase III

Latest Information Update: 01 Mar 2008

At a glance

  • Drugs Atorvastatin; Rosuvastatin
  • Indications Hyperlipoproteinaemia type II
  • Focus Therapeutic Use
  • Most Recent Events

    • 27 Mar 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top